Form 4: CervoMed CEO & President John J. Alam Buys More Stock
Insider Transaction Report
CervoMed Inc.'s CEO and President, John J. Alam, increased his beneficial ownership of common stock through open-market purchases in mid-November 2025.
Summary
- John J. Alam, who serves as CEO & President, Director, and a 10% Owner of CervoMed Inc. (CRVO), acquired additional shares of the company's common stock.
- On November 13, 2025, 4,447 shares were purchased at a price of $7.51 per share.
- On November 14, 2025, an additional 1,693 shares were acquired at a weighted average price of $7.55 per share, held within the John J. Alam Roth IRA.
- Also on November 14, 2025, 1,707 shares were acquired at a weighted average price of $7.57 per share, held within the Sylvie Gregoire Roth IRA, belonging to Mr. Alam's spouse.
- Following these transactions, the total beneficial ownership of common stock by John J. Alam stands at 1,473,271 shares.
- This total includes 1,471,578 shares held jointly by Mr. Alam and his spouse, Dr. Sylvie Gregoire, who is also a member of CervoMed Inc.'s Board of Directors.
Sentiment
Score: 9
Explanation: The CEO and President's significant open-market purchases of company stock indicate strong confidence in CervoMed Inc.'s future prospects and valuation, which is a highly positive signal for investors.
Positives
- The CEO and President, John J. Alam, a significant insider and 10% owner, increased his direct and indirect beneficial ownership of CervoMed Inc. common stock.
- All reported transactions were open-market purchases, indicating a direct investment at prevailing market prices.
- These insider purchases demonstrate strong confidence from key management in the company's current valuation and future prospects.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- 1,471,578 shares are held jointly by the Reporting Person, John J. Alam, and his spouse, Dr. Sylvie Gregoire, who is a member of the Issuer's Board of Directors.
- 1,707 shares were acquired and are held by the Sylvie Gregoire Roth IRA, belonging to the Reporting Person's spouse.
Stakeholder Impact
- Shareholders may interpret the insider purchases as a strong vote of confidence from management, potentially leading to increased investor interest and positive sentiment towards the stock.
- Employees may view management's personal investment as a sign of stability and belief in the company's strategic direction and long-term success.
Key Dates
| Date | Description |
|---|---|
| 11/13/2025 | Acquisition of 4,447 shares of Common Stock by John J. Alam in an open-market transaction. |
| 11/14/2025 | Acquisition of 1,693 shares of Common Stock by the John J. Alam Roth IRA in an open-market transaction. |
| 11/14/2025 | Acquisition of 1,707 shares of Common Stock by the Sylvie Gregoire Roth IRA (spouse's IRA) in an open-market transaction. |
| 11/17/2025 | Signature date of the Form 4 filing by attorney-in-fact for the Reporting Person. |
Recommendation
buyThe CEO and President, John J. Alam, a significant insider and 10% owner, made substantial open-market purchases of CervoMed Inc. common stock. This action signals strong conviction in the company's valuation and future performance, making it a compelling 'buy' signal for investors, as insiders typically buy when they believe the stock is undervalued or poised for growth.
Keywords
CervoMed Inc., CRVO, Insider Trading, Stock Purchase, CEO, Director, 10% Owner, John J. Alam, Form 4, Equity Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.